NDC 61755-018 – Inmazeb
Atoltivimab 241.7 mg/14.5mL; Maftivimab 241.7 mg/14.5mL; Odesivimab 241.7 mg/14.5mL · Injection, Solution · Intravenous
Product NDC61755-018
Product details
- Brand name
- Inmazeb
- Generic name
- Atoltivimab, maftivimab, and odesivimab-ebgn
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761169
- Marketed since
- October 14, 2020
- Listing expires
- December 31, 2026
Active ingredients
- Atoltivimab 241.7 mg/14.5mL
- Maftivimab 241.7 mg/14.5mL
- Odesivimab 241.7 mg/14.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61755-018-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00) | Oct 14, 2020 |
Other Inmazeb products
- 61755-019 Atoltivimab 483.3 mg/14.5mL; Maftivimab 483.3 mg/14.5mL; Odesivimab… · Injection, Solution · Regeneron Pharmaceuticals, Inc.